Literature DB >> 10694199

Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats.

M van Den Buuse1, R Catanzariti.   

Abstract

The mesolimbic dopamine system projects to a large number of forebrain areas and plays an important role in the regulation of locomotor activity, cognition and reward. We previously found evidence for a functional interaction between the mesolimbic dopamine system and circulating vasopressin and the present study was performed to test the hypothesis that mesolimbic dopamine stimulation modulates the cardiovascular effects of vasopressin. Sprague-Dawley rats were stereotaxically implanted with a guide cannula into the region of origin of the mesolimbic system, the ventral tegmental area, and instrumented with catheters into the abdominal aorta and jugular vein. One week later, separate groups of conscious rats were injected intravenously with 1, 3 or 10 ng kg(-1) of arginine-vasopressin or other vasopressor drugs before and after intra-ventral tegmental area injection of 10 nmol of neurotensin. Intra-ventral tegmental area injections of neurotensin had no significant effect on mean arterial pressure and heart rate but significantly potentiated the pressor response to intravenous administration of vasopressin when compared to saline-injections. However, the vasopressin-induced bradycardia was unaffected. Intravenous pretreatment with raclopride blocked the ability of neurotensin, injected into the ventral tegmental area, to potentiate the vasopressin-induced pressor response. Intra ventral tegmental area injections of neurotensin had no effect on the pressor response and bradycardia induced by intravenous angiotensin II or methoxamine. In conclusion, these results suggest that the mesolimbic dopamine system, in addition to its well-known role in the regulation of behaviour, modulates cardiovascular control by potentiating the effects of vasopressin on mean arterial pressure. British Journal of Pharmacology (2000) 129, 29 - 36

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694199      PMCID: PMC1621113          DOI: 10.1038/sj.bjp.0702982

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

Review 1.  Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats.

Authors:  M van den Buuse
Journal:  Clin Exp Pharmacol Physiol       Date:  1998-09       Impact factor: 2.557

2.  Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study.

Authors:  F Sotty; F Soulière; P Brun; G Chouvet; R Steinberg; P Soubrié; B Renaud; M F Suaud-Chagny
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

3.  Role of vasopressin in cardiovascular regulation.

Authors:  A W Cowley; E Q Quillen; M M Skelton
Journal:  Fed Proc       Date:  1983-12

4.  Regional expression of c-fos in rat brain following stimulation of the ventral tegmental area.

Authors:  J L Cornish; M van den Buuse
Journal:  Neurosci Lett       Date:  1996-12-06       Impact factor: 3.046

5.  Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat.

Authors:  R L Webb; J W Osborn; A W Cowley
Journal:  Am J Physiol       Date:  1986-12

6.  Stimulation in prefrontal cortex area inhibits cardiovascular and motor components of the defence reaction in rats.

Authors:  H A al Maskati; A W Zbrozyna
Journal:  J Auton Nerv Syst       Date:  1989-11

7.  Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra.

Authors:  A Y Deutch; S Y Tam; R H Roth
Journal:  Brain Res       Date:  1985-04-29       Impact factor: 3.252

8.  Effects of intravenous AVP on cardiac output, mesenteric hemodynamics, and splanchnic nerve activity.

Authors:  R Veelken; L Danckwart; P Rohmeiss; T Unger
Journal:  Am J Physiol       Date:  1989-08

9.  Inhibition of cardiac baroreflex sensitivity after central dopaminergic stimulation.

Authors:  M van den Buuse; D P Wilks; J L Cornish
Journal:  Clin Exp Pharmacol Physiol       Date:  1998 Jul-Aug       Impact factor: 2.557

Review 10.  Raclopride, a new selective ligand for the dopamine-D2 receptors.

Authors:  H Hall; C Köhler; L Gawell; L Farde; G Sedvall
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1988       Impact factor: 5.067

View more
  5 in total

1.  The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.

Authors:  Kathleen Deschamps; Réjean Couture
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

2.  Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Patricia E Molina; Jean Logan; S John Gatley; Andrew Gifford; Yu-Shin Ding; Christopher Wong; Naomi R Pappas; Wei Zhu; James M Swanson
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

3.  Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.

Authors:  Helaine De Brito Gariepy; Réjean Couture
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Effects of 12 Months Continuous Positive Airway Pressure on Sympathetic Activity Related Brainstem Function and Structure in Obstructive Sleep Apnea.

Authors:  Luke A Henderson; Rania H Fatouleh; Linda C Lundblad; David K McKenzie; Vaughan G Macefield
Journal:  Front Neurosci       Date:  2016-03-10       Impact factor: 4.677

5.  Evaluation of GABA Receptors of Ventral Tegmental Area in Cardiovascular Responses in Rat.

Authors:  Minoo Rasoulpanah; Fathmeh Kharazmi; Masoumeh Hatam
Journal:  Iran J Med Sci       Date:  2014-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.